- Previous Close
0.1300 - Open
0.0000 - Bid 0.1100 x --
- Ask 0.1500 x --
- Day's Range
0.1300 - 0.1300 - 52 Week Range
0.0750 - 0.4500 - Volume
0 - Avg. Volume
28,137 - Market Cap (intraday)
1.802M - Beta (5Y Monthly) 1.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
entheonbiomedical.comRecent News: ENBI.CN
View MorePerformance Overview: ENBI.CN
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENBI.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENBI.CN
View MoreValuation Measures
Market Cap
1.80M
Enterprise Value
1.67M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
12.40
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-70.93%
Return on Equity (ttm)
-137.90%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-317.92k
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
136.49k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-245.63k